A hundred researchers participate in the II Precision Medicine Symposium of the ibs.GRANADA
Organized by the ibs.GRANADA this scientific conference addresses the main advances in precision medicine of 14 multidisciplinary research groups from Granada.
A hundred researchers have participated this morning in the II Precision Medicine Symposium that has been held at the San Cecilio Clinical University Hospital in Granada to address the latest advances in this area of research. Organized by the Biosanitary Research Institute of Granada (ibs.GRANADA), the meeting has had a hybrid format, combining the presence of researchers in the hospital's auditorium with the attendance and making of presentations in virtual format to comply with the COVID-19 prevention standards.
The symposium included 14 presentations by researchers from the Ibs.GRANADA Precision Medicine area, coordinated by doctors Manuel Muñoz and Julio Gálvez. They have addressed questions of great interest such as the role of the 'clock genes' in cardiac aging, the benefits of the Mediterranean diet in patients with lupus erythematosus or osteoglycine as a biomarker of kidney disease in patients with type 2 diabetes.
The Conference was opened by Manuel Reyes, managing director of the San Cecilio Clinic, the scientific director of IBS.GRANADA, María José Sánchez, the managing director of the Virgen de las Nieves Hospital, María de los Ángeles García, (remotely) and Francisco O'Valle as representative of the Vice-Rector's Office for Research and Transfer of the University of Granada.
In the opening presentation, Joaquín Dopazo, director of the Bioinformatics Area of the Progreso y Salud Foundation, delved into the practical applications of genomic and clinical big data with artificial intelligence in health. For Dr. Dopazo "big data opens a wide range of possibilities for health research, given the large amount of genomic information that is generated every day and that properly managed can help us achieve important advances".
However, according to Dr. Dopazo, "the correct treatment of this volume of data requires the use of computing and will require in the near future new professional profiles that respond to the new needs posed by the research."
The Precision Medicine area is one of the main bastions of Ibs.GRANADA with 17 currently active research projects and 35 research grants awarded in 2020. Currently, it has 24 research groups and works in three main lines: diagnosis based in omic data, biomarkers for clinical diagnosis, disease mechanism and development of new therapies.
Its creation arises from the need to address the challenge of "personalized medicine" and to translate the results of research into practical applications that benefit health. It is about adapting medicine to the characteristics of each person, offering personalized responses in medical interventions.
About the ibs.GRANADA
The Instituto de Investigación Biosanitaria ibs.GRANADA, is the only center accredited by the Carlos III Health Institute (ISCIII) that develops biomedical research of excellence in Granada and one of the four accredited in Andalusia by the ISCIII.
The ibs.GRANADA is structured in four Scientific Areas: Oncology, Precision Medicine, Epidemiology and Public Health and Technology and Advanced Therapies that develop an intense research activity and lead the transfer of research results to society, which are reflected in the 903 publications made in scientific journals, totaling 3.550 impact factor points, as well as 32 patents applied for during 2020.
Currently, the Institute brings together more than 983 professionals and 69 multidisciplinary research groups that comprise, from the University of Granada, the Virgen de las Nieves University Hospital, the San Cecilio Clinical University Hospital, the Andalusian School of Public Health and Primary Care centers of the Granada-Metropolitan Health District.
The main objectives of ibs.GRANADA are to promote biomedical, clinical and epidemiological research carried out by the different groups attached to the institute and to facilitate translational research in Granada hospitals. This research activity translates into the generation of knowledge and the transfer of scientific advances towards the prevention, diagnosis and treatment of priority health problems in Andalusia.